Nabi-HB

Hepatitis B Immune Globulin (Human)

ADMA Biologics

Nabi-HB, Hepatitis B Immune Globulin (Human), is indicated for treatment of acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infection in the following settings:

• Acute Exposure to Blood Containing HBsAg
  Following either parenteral exposure (needlestick, bit, sharps), direct mucous membrane contact (accidental splash), or oral ingestion (pipetting accident), involving HBsAg-positive materials such as blood, plasma, or serum.
• Perinatal Exposure of Infants Born to HBsAg-positive Mothers
  Infants born to mothers positive for HBsAg with or without HBeAg.

Refrigerate between 2 to 8 ^oC (36 to 46 ^oF).  Do not freeze.  Do not use after expiration date.  Use within 6 hours after the vial has been entered.